Shareholders Foundation, Inc.

MiMedx Group Inc (NASDAQ:MDXG) Investor Alert: Deadline in Lawsuit on April 20, 2015

A Deadline is coming up on April 20, 2015 in the lawsuit for investors in MiMedx Group Inc (NASDAQ:MDXG) and NASDAQ:MDXG stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com

San Diego, CA -- (SBWIRE) -- 04/20/2015 -- A deadline is coming up on April 20, 2015 in the lawsuit filed for investors of MiMedx Group Inc (NASDAQ:MDXG) over alleged securities laws violations by MiMedx Group.

Investors who purchased shares of MiMedx Group Inc (NASDAQ:MDXG) have certain options and for certain NASDAQ:MDXG shareholders are strict and short deadlines running. Deadline: April 20, 2015. NASDAQ:MDXG stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of MiMedx Group Inc (NASDAQ:MDXG) common shares between February 26, 2014 and December 31, 2014, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the defendants made allegedly false and/or misleading statements and/or failed to disclose that MiMedx Group Inc was in violation of federal regulations by engaging in improper marketing and sales practices, and that as a result of the foregoing, MiMedx Group Inc's statements were materially false and misleading at all relevant times.

On September 4, 2013, MiMedx Group Inc confirmed that it is in receipt of an "Untitled Letter" from the Food and Drug Administration ("FDA") in connection with MiMNedx Group Inc's Amnion / Chorion Injectable products' eligibility for marketing solely under Section 361 of the Public Health Service Act.

On Dec. 31, 2014 MiMedx Group Inc announced that it has received a subpoena from the Office of Inspector General ("OIG") of the Department of Health and Human Services ("HHS") in connection with a civil investigation into matters primarily related to the Company's sales and marketing activities. MiMedx Group Inc said it intends to cooperate fully with the government in its investigation, and the Company will attempt to expedite the process.

The same day MiMedx Group Inc announced that it had filed a lawsuit against one of its competitors, Organogenesis, Inc. for allegedly tortious interference of contract, alleging that it had interfered with MiMedx Group Inc's dealings with the Veterans Administration. Within a matter of weeks, MiMedx Group Inc voluntarily dismissed the lawsuit.

Shares of MiMedx Group Inc (NASDAQ:MDXG) declined from $11.73 per share on December 31, 2014, to as low as $7.92 per share on February 2, 2015.